Veterinary Medicines

COLISUIN-TP ΕΝΕΣΙΜΟ ΓΑΛΑΚΤΩΜΑ ΓΙΑ ΧΟΙΡΟΥΣ

Authorised
  • Escherichia coli, fimbrial adhesin F4ab
  • Escherichia coli, fimbrial adhesin F4ac
  • Escherichia coli, fimbrial adhesin F5
  • Escherichia coli, serotype K85:987P (fimbrial adhesin F6), Inactivated
  • Escherichia coli, LT toxoid
Download as PDF

Product identification

Medicine name:
COLISUIN-TP ΕΝΕΣΙΜΟ ΓΑΛΑΚΤΩΜΑ ΓΙΑ ΧΟΙΡΟΥΣ
Active substance:
  • Escherichia coli, fimbrial adhesin F4ab
  • Escherichia coli, fimbrial adhesin F4ac
  • Escherichia coli, fimbrial adhesin F5
  • Escherichia coli, serotype K85:987P (fimbrial adhesin F6), Inactivated
  • Escherichia coli, LT toxoid
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Escherichia coli, fimbrial adhesin F4ab
    3280.00
    haemagglutinating units
    /
    1.00
    Dose
  • Escherichia coli, fimbrial adhesin F4ac
    3280.00
    haemagglutinating units
    /
    1.00
    Dose
  • Escherichia coli, fimbrial adhesin F5
    160.00
    unknown
    /
    1.00
    Dose
  • Escherichia coli, serotype K85:987P (fimbrial adhesin F6), Inactivated
    64.00
    unknown
    /
    1.00
    Dose
  • Escherichia coli, LT toxoid
    32.00
    Clinical unit
    /
    1.00
    Dose
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        21
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AB02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Hipra S.A.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 30803/17-06-2003/K-0121801
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."